Ilyang Pharmaceutical Co.,Ltd (KRX:007570)

KRX:007570 Revenue

Ilyang Pharmaceutical Co.,Ltd had revenue of 61.98B KRW in the quarter ending March 31, 2025, with 5.55% growth. This brings the company's revenue in the last twelve months to 272.12B, up 11.04% year-over-year. In the year 2024, Ilyang Pharmaceutical Co.,Ltd had annual revenue of 268.86B with 0.82% growth.

• Revenue (ttm): 272.12B
• Revenue Growth: +11.04%
• P/S Ratio: 0.84
• Revenue / Employee: 406.15M
• Employees: 670
• Market Cap: 229.49B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	268.86B	2.19B	0.82%
Dec 31, 2023	266.67B	18.90B	7.63%
Dec 31, 2022	247.77B	5.26B	2.17%
Dec 31, 2021	242.51B	-100.82B	-29.36%
Dec 31, 2020	343.33B	18.76B	5.78%